Filed: 2/17/2026ACC: 0000935836-26-000101
📋 What this filing means
ECOR1 CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 28 equity positions with a total reported market value of $2.20B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
28
Positions
$2.20B
Total AUM (reported)
87.72M
Total Shares
Allocation by class
COM$1.61B73.2%
SHS USD$290.10M13.2%
SPONSORED ADS$101.16M4.6%
NAMEN AKT$72.85M3.3%
COM NEW$59.43M2.7%
SPON ADR$54.51M2.5%
*W EXP 02/10/202$8.63M0.4%
Portfolio Concentration
Top 3$1.28B57.9%
4–10$588.24M26.7%
11–25$333.47M15.1%
Rest$5.37M0.2%
Top 3 weight
57.9%
Top 10 weight
84.6%
Voting Authority Distribution
Total shares with voting rights: 87.72M
Sole
Full voting authority
87.72M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole28
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings28
Rows:
ZYMEWORKS INC
SOLEShares22.97M
TypeSH
Market value$604.81M
27.44%
Sole
22.97M
Shared
0.00
None
0.00
ANAPTYSBIO INC
SOLEShares7.88M
TypeSH
Market value$382.03M
17.33%
Sole
7.88M
Shared
0.00
None
0.00
JAZZ PHARMACEUTICALS PLC
SOLEShares1.71M
TypeSH
Market value$290.10M
13.16%
Sole
1.71M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares4.29M
TypeSH
Market value$199.61M
9.06%
Sole
4.29M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares3.12M
TypeSH
Market value$77.91M
3.53%
Sole
3.12M
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares1.39M
TypeSH
Market value$72.85M
3.31%
Sole
1.39M
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
SOLEShares2.12M
TypeSH
Market value$66.98M
3.04%
Sole
2.12M
Shared
0.00
None
0.00
IMMUNOME INC
SOLEShares2.86M
TypeSH
Market value$61.34M
2.78%
Sole
2.86M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares6.73M
TypeSH
Market value$55.04M
2.50%
Sole
6.73M
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares1.67M
TypeSH
Market value$54.51M
2.47%
Sole
1.67M
Shared
0.00
None
0.00
XENCOR INC
SOLEShares3.32M
TypeSH
Market value$50.81M
2.31%
Sole
3.32M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares1.06M
TypeSH
Market value$44.21M
2.01%
Sole
1.06M
Shared
0.00
None
0.00
BRIDGEBIO ONCOLOGY THERAPEUT
SOLEShares2.82M
TypeSH
Market value$35.35M
1.60%
Sole
2.82M
Shared
0.00
None
0.00
ETON PHARMACEUTICALS INC
SOLEShares2.03M
TypeSH
Market value$34.34M
1.56%
Sole
2.03M
Shared
0.00
None
0.00
ZENAS BIOPHARMA INC
SOLEShares789.50K
TypeSH
Market value$28.67M
1.30%
Sole
789.50K
Shared
0.00
None
0.00
NEUROGENE INC
SOLEShares1.27M
TypeSH
Market value$26.19M
1.19%
Sole
1.27M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares334.38K
TypeSH
Market value$23.26M
1.06%
Sole
334.38K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares450K
TypeSH
Market value$20.76M
0.94%
Sole
450K
Shared
0.00
None
0.00
AQUESTIVE THERAPEUTICS INC
SOLEShares2.63M
TypeSH
Market value$16.96M
0.77%
Sole
2.63M
Shared
0.00
None
0.00
VOYAGER THERAPEUTICS INC
SOLEShares4M
TypeSH
Market value$15.73M
0.71%
Sole
4M
Shared
0.00
None
0.00
ATARA BIOTHERAPEUTICS INC
SOLEShares573.18K
TypeSH
Market value$10.37M
0.47%
Sole
573.18K
Shared
0.00
None
0.00
MANNKIND CORP
SOLEShares1.66M
TypeSH
Market value$9.41M
0.43%
Sole
1.66M
Shared
0.00
None
0.00
NUVATION BIO INC
SOLEShares963.33K
TypeSH
Market value$8.63M
0.39%
Sole
963.33K
Shared
0.00
None
0.00
EVOLUS INC
SOLEShares675K
TypeSH
Market value$4.49M
0.20%
Sole
675K
Shared
0.00
None
0.00
IBIO INC
SOLEShares2.23M
TypeSH
Market value$4.30M
0.20%
Sole
2.23M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ZYMEWORKS INCSOLE | COM | 22.97M | SH | $604.81M 27.44% | 22.97M | 0.00 | 0.00 |
ANAPTYSBIO INCSOLE | COM | 7.88M | SH | $382.03M 17.33% | 7.88M | 0.00 | 0.00 |
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 1.71M | SH | $290.10M 13.16% | 1.71M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 4.29M | SH | $199.61M 9.06% | 4.29M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 3.12M | SH | $77.91M 3.53% | 3.12M | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 1.39M | SH | $72.85M 3.31% | 1.39M | 0.00 | 0.00 |
MBX BIOSCIENCES INCSOLE | COM | 2.12M | SH | $66.98M 3.04% | 2.12M | 0.00 | 0.00 |
IMMUNOME INCSOLE | COM | 2.86M | SH | $61.34M 2.78% | 2.86M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 6.73M | SH | $55.04M 2.50% | 6.73M | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 1.67M | SH | $54.51M 2.47% | 1.67M | 0.00 | 0.00 |
XENCOR INCSOLE | COM | 3.32M | SH | $50.81M 2.31% | 3.32M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 1.06M | SH | $44.21M 2.01% | 1.06M | 0.00 | 0.00 |
BRIDGEBIO ONCOLOGY THERAPEUTSOLE | COM NEW | 2.82M | SH | $35.35M 1.60% | 2.82M | 0.00 | 0.00 |
ETON PHARMACEUTICALS INCSOLE | COM | 2.03M | SH | $34.34M 1.56% | 2.03M | 0.00 | 0.00 |
ZENAS BIOPHARMA INCSOLE | COM | 789.50K | SH | $28.67M 1.30% | 789.50K | 0.00 | 0.00 |
NEUROGENE INCSOLE | COM | 1.27M | SH | $26.19M 1.19% | 1.27M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 334.38K | SH | $23.26M 1.06% | 334.38K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 450K | SH | $20.76M 0.94% | 450K | 0.00 | 0.00 |
AQUESTIVE THERAPEUTICS INCSOLE | COM | 2.63M | SH | $16.96M 0.77% | 2.63M | 0.00 | 0.00 |
VOYAGER THERAPEUTICS INCSOLE | COM | 4M | SH | $15.73M 0.71% | 4M | 0.00 | 0.00 |
ATARA BIOTHERAPEUTICS INCSOLE | COM NEW | 573.18K | SH | $10.37M 0.47% | 573.18K | 0.00 | 0.00 |
MANNKIND CORPSOLE | COM NEW | 1.66M | SH | $9.41M 0.43% | 1.66M | 0.00 | 0.00 |
NUVATION BIO INCSOLE | *W EXP 02/10/202 | 963.33K | SH | $8.63M 0.39% | 963.33K | 0.00 | 0.00 |
EVOLUS INCSOLE | COM | 675K | SH | $4.49M 0.20% | 675K | 0.00 | 0.00 |
IBIO INCSOLE | COM NEW | 2.23M | SH | $4.30M 0.20% | 2.23M | 0.00 | 0.00 |
Page 1 of 2